SEC FORM 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:		3235-0104
Expires:	December 31, 2014
Estimated average burden
hours per response:		0.5

1. Name and Address of Reporting Person ^*

Bergwerk Dov

(Last)

(First)

(Middle)

C/O TEVA PHARMACEUTICAL INDUSTRIES LTD.

124 DVORA HA'NEVIA STREET

(Street)

TEL AVIV

6944020

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
09/29/2026

3. Issuer Name and Ticker or Trading Symbol
TEVA PHARMACEUTICAL INDUSTRIES LTD [ TEVA ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
Interim Cheif Legal Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	11,943	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Options (right to buy)	⁽¹⁾	03/03/2027	Ordinary Shares	17,505	34.7	D
Stock Options (right to buy)	⁽²⁾	05/24/2027	Ordinary Shares	8,755	28.98	D
Restricted Share Units	⁽³⁾	⁽³⁾	Ordinary Shares	16,742	⁽⁴⁾	D
Restricted Share Units	⁽⁵⁾	⁽⁵⁾	Ordinary Shares	16,742	⁽⁴⁾	D
Restricted Share Units	⁽⁶⁾	⁽⁶⁾	Ordinary Shares	10,719	⁽⁴⁾	D
Restricted Share Units	⁽⁷⁾	⁽⁷⁾	Ordinary Shares	13,673	⁽⁴⁾	D
Restricted Share Units	⁽⁸⁾	⁽⁸⁾	Ordinary Shares	7,771	⁽⁴⁾	D

Explanation of Responses:

1. Stock options were granted on March 3, 2017, with 4,376 having vested on each of March 3, 2018, March 3, 2019 and March 3, 2020 and 4,377 having vested on March 3, 2021.

2. Stock options were granted on May 24, 2017, with 2,188 having vested on each of May 24, 2018, May 24, 2019 and May 24, 2020 and 2,191 having vested on May 24, 2021.

3. Restricted share units were granted on November 15, 2023, with 8,370 vested on each of November 15, 2024, November 15, 2025, 8,370 vesting on November 15, 2026, and 8,372 vesting on November 15, 2027.

4. Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.

5. Restricted share units were granted on March 4, 2024, with 8,370 vested on each of March 4, 2025 and March 4, 2026, 8,370 vesting on March 4, 2027, and 8,372 vesting on March 4, 2028.

6. Restricted share units were granted on March 5, 2025, with 3,573 vested on March 5, 2026, and 3,573 vesting on each of March 5, 2027, March 5, 2028 and March 5, 2029.

7. Restricted share units were granted on March 4, 2026, with 3,418 vesting on each of March 4, 2027, March 4, 2028 and March 4, 2029, and 3,419 vesting on March 4, 2030.

8. Restricted share units were granted on March 3, 2023, with 7,768 vested on each of March 3, 2024, March 3, 2025 and March 3, 2026 and 7,771 vesting on March 3, 2027.

	/s/ Dov Bergwerk	10/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.